Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
WDFY3-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC16A1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SLC18A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ADAM32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BNIP3L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDH26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRTM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AHI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FUCA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FKTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PALLD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THBD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HGH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENY2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTHFD2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CENPF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on